You have 9 free searches left this month | for more free features.

Ivacaftor

Showing 26 - 50 of 197

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Cystic Fibrosis Trial in Worldwide (ELX/TEZ/IVA, IVA)

Completed
  • Cystic Fibrosis
  • Chermside, Australia
  • +28 more
Jan 17, 2023

Non-cystic Fibrosis Bronchiectasis Trial in Atlanta (Trikafta)

Recruiting
  • Non-cystic Fibrosis Bronchiectasis
  • Atlanta, Georgia
    The Emory Clinic
Feb 15, 2023

Gut Imaging for Function and Transit in Cystic Fibrosis 3 Junior

Active, not recruiting
  • Cystic Fibrosis
  • Elexacaftor / Ivacaftor / Tezacaftor
  • Nottingham, Nottinghamshire, United Kingdom
    Queen's Medical Centre
Jan 24, 2023

Cystic Fibrosis Trial in Canada, United States (LUM/IVA)

Active, not recruiting
  • Cystic Fibrosis
  • Birmingham, Alabama
  • +22 more
Nov 30, 2022

Cystic Fibrosis Trial in Worldwide (ELX/TEZ/IVA, IVA, Placebo (matched to ELX/TEZ/IVA))

Completed
  • Cystic Fibrosis
  • Nedlands, Australia
  • +33 more
Jul 1, 2022

Trikafta/Kaftrio and Pseudomonas Aeruginosa

Recruiting
  • Cystic Fibrosis
    • Milan, Italy
    • +1 more
    Jan 9, 2023

    Cystic Fibrosis Trial in Worldwide (ELX/TEZ/IVA, IVA)

    Enrolling by invitation
    • Cystic Fibrosis
    • Tucson, Arizona
    • +21 more
    Jul 21, 2022

    Cystic Fibrosis Trial in Worldwide (ELX/TEZ/IVA, IVA)

    Completed
    • Cystic Fibrosis
    • Tucson, Arizona
    • +21 more
    Jul 1, 2022

    Cystic Fibrosis Trial in Birmingham (Trikafta, symdeko/Trikafta, Ivacaftor/Trikafta)

    Completed
    • Cystic Fibrosis
    • Birmingham, Alabama
      University of Alabama at Birmingham
    Feb 7, 2022

    Glucose Tolerance Abnormalities in Cystic Fibrosis Homozygous

    Completed
    • Cystic Fibrosis Homozygous for Phe 508 Del CFTR
    • Glucose Intolerance or Newly Diagnosis Diabetes
    • Lumacaftor-Ivacaftor treatment
    • Strasbourg, Alsace, France
    • +12 more
    Nov 23, 2021

    Cystic Fibrosis Trial in Worldwide (ELX/TEZ/IVA, IVA)

    Completed
    • Cystic Fibrosis
    • Adelaide, Australia
    • +40 more
    Aug 4, 2022

    Cystic Fibrosis Trial in Worldwide (ELX/TEZ/IVA, IVA)

    Active, not recruiting
    • Cystic Fibrosis
    • Nedlands, Australia
    • +33 more
    Feb 4, 2022

    Cystic Fibrosis Trial (ELX/TEZ/IVA, IVA)

    Approved for marketing
    • Cystic Fibrosis
    • (no location specified)
    Jul 8, 2021

    Primary Ciliary Dyskinesia Trial in Worldwide (VX-371, Hypertonic Saline, Placebo (0.17% saline))

    Completed
    • Primary Ciliary Dyskinesia
    • Birmingham, Alabama
    • +33 more
    Nov 18, 2021

    Lumacaftor/Ivacaftor on F508del Homozygous Cystic Fibrosis

    Completed
    • Cystic Fibrosis
    • Lumacaftor, Ivacaftor Drug Combination
    • (no location specified)
    Feb 2, 2021

    Cystic Fibrosis Trial in Nottingham (Tezacaftor/Ivacaftor + Ivacaftor, Placebo oral tablet)

    Completed
    • Cystic Fibrosis
    • Tezacaftor/Ivacaftor + Ivacaftor
    • Placebo oral tablet
    • Nottingham, Nottinghamshire, United Kingdom
      Nottingham University Hospitals NHS Trust
    Jan 14, 2021

    Cystic Fibrosis Trial in Worldwide (TEZ/IVA, IVA)

    Active, not recruiting
    • Cystic Fibrosis
    • Birmingham, Alabama
    • +54 more
    Oct 28, 2022

    Cystic Fibrosis Trial in Worldwide (ELX/TEZ/IVA, TEZ/IVA, IVA)

    Completed
    • Cystic Fibrosis
    • Chermside, Australia
    • +34 more
    Jul 23, 2021

    Impact of Triple Combination CFTR Therapy on Sinus Disease.

    Recruiting
    • Cystic Fibrosis
    • Elexacaftor-tezacaftor-ivacaftor exposure
    • Denver, Colorado
      National Jewish Health
    Mar 9, 2021

    Cystic Fibrosis Trial in Birmingham, Atlanta, Houston (Trikafta)

    Recruiting
    • Cystic Fibrosis
    • Birmingham, Alabama
    • +2 more
    Mar 25, 2022

    Cystic Fibrosis Trial in Canada, United States (LUM, IVA)

    Completed
    • Cystic Fibrosis
    • Birmingham, Alabama
    • +26 more
    Nov 26, 2021

    Cystic Fibrosis Trial in Vancouver (Trikafta)

    Recruiting
    • Cystic Fibrosis
    • Vancouver, British Columbia, Canada
    • +1 more
    Jan 6, 2022

    Long QT Syndrome Trial in Milano (Lumacaftor / Ivacaftor, Orkambi® Oral Tablet)

    Recruiting
    • Long QT Syndrome
    • Lumacaftor / Ivacaftor, Orkambi® Oral Tablet
    • Milano, Italy
      Istituto Auxologico Italiano, Ospedale San Luca
    Aug 24, 2021

    Cystic Fibrosis, Adherence, Medication Trial in San Antonio (Patch Cap, Patch App)

    Completed
    • Cystic Fibrosis
    • Adherence, Medication
    • Patch Cap
    • Patch App
    • San Antonio, Texas
      The University of Texas Health Science Center at San Antonio
    Jan 3, 2022